La OMS recomienda el uso de anlogos GLP-1 para combatir la epidemia mundial de obesidad Salud El organismo tambin pide a las farmacuticas que los hagan ms accesibles aumentando la produccin, escalonando los precios y que autoricen a otras empresas a fabricarlos y venderlos para bajar los precios La Organizacin Mundial de la Salud (OMS) ha emitido hoy una recomendacin en favor del uso de tres medicamentos anlogos del GLP-1, concebidos originalmente para tratar la diabetes tipo 2, en pacientes con obesidad, una enfermedad que afecta a 1.000 millones de personas, cifra que podra duplicarse en apenas cinco aos
Semaglutide, a GLP-1 receptor agonist, works by mimicking a hormone in the body that regulates insulin and appetite, while tirzepatide works by targeting multiple hormones involved in glucose and weight regulation
We have shiny explanations (along with product lists) about others as well: Methylene Bis-Benzotriazolyl Tetramethylbutylphenol, aka Tinosorb M, the good buddy of our current molecule Tinosorb S Tris-Biphenyl Triazine, aka Tinosorb A2B, the newest addition to the Tinosorb family that protects strongly in an in-between wavelength that most other filters miss Ethylhexyl Triazone, aka Uvinul T 150, another new generation sunscreen agent with super-high UVB protection Diethylamino Hydroxybenzoyl Hexyl Benzoate, aka Uvinul A Plus, a new generation sunscreen for UVA protection The famous Avobenzone
Use DrugPatentWatch to understand where the thickets are, and dont try to walk through themfind the paths around them
What does GLP-1 do in the body
